CSIMarket Company Name, Ticker, Competitors, else..


Lumos Pharma Inc   (NASDAQ: LUMO)
Other Ticker:  
 

Lumos Pharma Inc

LUMO's Fundamental analysis



Looking into Lumos Pharma Inc growth rates, revenue grew by 10271.43 % in the third quarter of 2024 from the same quarter a year ago. Ranking at No. 10

Major Pharmaceutical Preparations industry recorded growth of revenues by 10.2 %

Lumos Pharma Inc net loss decreased from $-8 millions, to $-7 millions in third quarter of 2024,

• More on LUMO's Growth


Lumos Pharma Inc
realized a net loss in trailing twelve months.

Lumos Pharma Inc realized cash reduction of $ -2.65 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 16.39.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.14.


• More on LUMO's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 95,870
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.59

Lumos Pharma Inc
realized net loss in trailing twelve months.

Lumos Pharma Inc realized cash outflow of $ -2.65per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 16.39.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.14.

Lumos Pharma Inc Price to Book Ratio is at 7.35 lower than Industry Avg. of 110.91. and higher than S&P 500 Avg. of 0.02

• More on LUMO's Valuation

•  Market Capitalization (Millions $) 36
•  Shares Outstanding (Millions) 8
•  Employees 23
•  Revenues (TTM) (Millions $) 2
•  Net Income (TTM) (Millions $) -35
•  Cash Flow (TTM) (Millions $) -22
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 95,870
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 0.59

•  Market Capitalization (Millions $) 36
•  Shares Outstanding (Millions) 8
•  Employees 23
•  Revenues (TTM) (Millions $) 2
•  Net Income (TTM) (Millions $) -35
•  Cash Flow (TTM) (Millions $) -22
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 2.71
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 2.53
•  Asset Turnover Ratio (TTM) 0.08
•  Inventory Turnover Ratio (TTM) -





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.